Selected publications

*indicates equal contribution and # indicates corresponding authorship.

  • Karimzadeh M, Jandaghi P, Papadakis Al, Trainor S, Rung J, Gonzàkez-Porta M, Scelo G, Vasudev NS, Brazma A, Huang S, Banks RE, Lathrop M, Najafabadi HS, Riazalhosseini Y (2018): Aberration hubs in protein interaction networks highlight actionable targets in cancer. Oncotarget 9:25166-80.
  • Perron G, Jandaghi P, Solanki S, Safisamghabadi M, Storoz C, Karimzadeh M, Papadakis Al, Arseneault M, Scelo G, Banks RE, Tost J, Lathrop M, Tanguay S, Brazma A, Huang S, Brimo F, Najafabadi HS, Riazalhosseini Y (2018): A General Framework for Interrogation of mRNA Stability Programs Identifies RNA-Binding Proteins that Govern Cancer Transcriptomes. Cell Reports 23(6): 1639-50.
  • Robinson CM, Lefebvre F, Poon BP, Bousard A, Fax X, Lathrop M, Tost J, Kim WY, Riazalhosseini Y, Ohh M (2018): Consequences of VHL Loss on global DNA Methylome. Scientific Reports 8(1):3313.
  • Mishra RR, Belder N, Ansari SA, Kayhan M, Bal H, Raza U, Ersan PG, Tokat UM, Eyupoglu E, Saatci O, Jandaghi P, Wiemann S, Under A, Cekic C, Riazalhosseini Y, Sahin O (2018): Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer. Clinical Cancer Research 24(8):1987-2001.
  • Wever CM, Geoffrion D, Grande BM, Yu S, Alcaide M, Lemaire M, Riazalhosseini Y, Hebert J, Gavino C, Vinh DC, Petrogiannis-Haliotis T, Dmitrienko S, Mann KK, Morin RD, Johnson NA (2018): The genomic landscape of two Burkitt lymphoma cases and derived cell lines: a comparison between primary and relapse samples. Leukemia & Lymphoma, doi: 10.1080/10428194.2017.1413186.
  • Mehdi A, Riazalhosseini Y (2017): Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences 18(8):1774. 
  • Arseneault M, Monlong J, Vasudev NS, Laskar RS, Safisamghabadi M, Harnden P, Egevad L, Nourbehesht N, Panichnantakul P, Holcatova I, Brisuda A, Janout V, Kollarova H, Foretova L, Navratilova M, Mates D, Kinga V, Zaridze D, Mukeria A, Jandaghi P, Brennan P, Brazma A, Tost J, Scelo G, Banks RE, Lathrop M, Bourque G, Riazalhosseini Y (2017): Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma. Scientific Reports, doi: 10.1038/srep44876.
  • Yasser Riazalhosseini# and Mark Lathrop# (2016): Precision medicine from the renal cancer genome. Nature Reviews Nephrology (in press).
  • Pudchalaluck Panichnantakul, Mathieu Bourgey, Alexandre Montpetit, Guillaume Bourque, Yasser Riazalhosseini# (2016): RNA-seq as a tool to study the tumor microenvironment. Methods in Molecular Biology 1458:311-37.
  • Pouria Jandaghi, Hamed S. Najafabadi, Andrea S. Bauer, Andreas I. Papadakis, Matteo Fassan, Anita Hall, Anie Monast, Magnus von Knebel Doeberitz, John P. Neoptolemos, Eithne Costello, William Greenhalf, Aldo Scarpa, Bence Sipos, Daniel Auld, Mark Lathrop, Morag Park, Markus W. Büchler, Oliver Strobel, Thilo Hackert, Nathalia A. Giese, George Zogopoulos, Veena Sangwan, Sidong Huang, Yasser Riazalhosseini#, Jörg D. Hoheisel (2016): Expression of DRD2 is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. Gastroenterology, doi: 10.1053/j.gastro.2016.08.040.

Visit Pubmed for a full list of publications.